Status | Study |
RECRUITING |
Study Name: A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma Condition: Neuroblastoma Date: 2023-09-21 Interventions: Comprised of the immunological adjuvant OPT-821 (QS-21) |
RECRUITING |
Study Name: Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed or Refractory Neuroblastoma Condition: Neuroblastoma Date: 2022-05-25 Interventions: The cell dose will be based on the subject's body weight.Subjects will receive a single infusion of third party, ex vivo expanded, froze |
RECRUITING |
Study Name: Open-Label Study of 18F-mFBG for Imaging Neuroblastoma Condition: Neuroblastoma Date: 2021-01-18 Interventions: Positron-emitting tomography (PET) (either PET/CT or PET/MR) imaging agent |
Recruiting |
Study Name: Neuroblastoma Precision Trial Condition: Neuroblastoma Date: 2016-06-03 Interventions: Other: Gene panel sequencing of tumor specimens Archival or biopsied tumor specimens will undergo gene p |
Not yet recruiting |
Study Name: Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells Condition: Neuroblastoma Date: 2015-09-16 Interventions: Drug: Ch14.18 17.5 mg/m2/day o |
Active, not recruiting |
Study Name: A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma Condition: Neuroblastoma Date: 2013-02-21 Interventions: Biological: Activated T lymphocyte intravenous dripping of 200 ml (10^9~2*10^10 lymphocytes) for 1 hour. |
RECRUITING |
Study Name: High Dose Chemotherapy and Autologous Transplant for Neuroblastoma Condition: Neuroblastoma Date: 2012-01-31 Interventions: Carboplatin intravenously (IV), 425 mg/m2/dose (or if ? 12kg, 14.2 mg/kg/dose) once daily x 4 doses on days 7 through 4 pretranspl |
Completed |
Study Name: Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma Condition: Neuroblastoma Date: 2011-12-15 Interventions: Genetic: fluorescence in situ hybridization |
Recruiting |
Study Name: Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET) Condition: Neuroblastoma Date: 2011-02-22 Interventions: Device: FLT-PET PET scan will be conducted at diagnosis, at the end of the first cycle of treatment and |
Completed |
Study Name: Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide Condition: Neuroblastoma Date: 2010-01-26 Interventions: Drug: DFMO |